Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$73.27 - $83.09 $190,355 - $215,867
2,598 New
2,598 $210,000
Q2 2023

Aug 09, 2023

SELL
$76.01 - $86.7 $68,637 - $78,290
-903 Reduced 24.1%
2,844 $219,000
Q1 2023

Apr 20, 2023

SELL
$77.31 - $88.08 $23,270 - $26,512
-301 Reduced 7.44%
3,747 $311,000
Q4 2022

Feb 02, 2023

SELL
$62.32 - $89.47 $16,390 - $23,530
-263 Reduced 6.1%
4,048 $348,000
Q3 2022

Nov 15, 2022

BUY
$59.54 - $68.01 $238 - $272
4 Added 0.09%
4,311 $266,000
Q2 2022

Aug 04, 2022

SELL
$57.72 - $65.01 $4,040 - $4,550
-70 Reduced 1.6%
4,307 $266,000
Q1 2022

May 02, 2022

SELL
$57.92 - $72.58 $1,795 - $2,249
-31 Reduced 0.7%
4,377 $260,000
Q4 2021

Jan 24, 2022

SELL
$64.88 - $73.64 $648 - $736
-10 Reduced 0.23%
4,408 $320,000
Q3 2021

Oct 12, 2021

SELL
$67.69 - $73.03 $288,968 - $311,765
-4,269 Reduced 49.14%
4,418 $309,000
Q2 2021

Jul 28, 2021

SELL
$63.47 - $69.35 $317 - $346
-5 Reduced 0.06%
8,687 $598,000
Q1 2021

May 07, 2021

BUY
$60.0 - $68.46 $252,840 - $288,490
4,214 Added 94.1%
8,692 $562,000
Q4 2020

Jan 21, 2021

BUY
$56.65 - $64.55 $253,678 - $289,054
4,478 New
4,478 $261,000
Q3 2020

Oct 29, 2020

SELL
$62.1 - $78.08 $168,539 - $211,909
-2,714 Closed
0 $0
Q2 2020

Jul 21, 2020

SELL
$72.34 - $84.0 $4,919 - $5,712
-68 Reduced 2.44%
2,714 $209,000
Q1 2020

Apr 13, 2020

SELL
$62.63 - $80.22 $162,023 - $207,529
-2,587 Reduced 48.18%
2,782 $208,000
Q4 2019

Jan 06, 2020

BUY
$61.62 - $67.78 $330,837 - $363,910
5,369 New
5,369 $349,000
Q2 2019

Jul 15, 2019

SELL
$61.87 - $69.38 $198,355 - $222,432
-3,206 Closed
0 $0
Q1 2019

Jun 10, 2019

BUY
$62.53 - $70.05 $200,471 - $224,580
3,206 New
3,206 $208,000
Q4 2018

Jan 15, 2019

SELL
$60.54 - $79.0 $227,388 - $296,724
-3,756 Closed
0 $0
Q3 2018

Oct 10, 2018

SELL
$71.28 - $78.92 $10,834 - $11,995
-152 Reduced 3.89%
3,756 $290,000
Q2 2018

Aug 07, 2018

SELL
$64.88 - $75.68 $520,013 - $606,575
-8,015 Reduced 67.22%
3,908 $277,000
Q1 2018

May 10, 2018

BUY
$72.84 - $88.8 $868,471 - $1.06 Million
11,923 New
11,923 $899,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Altfest L J & CO Inc Portfolio

Follow Altfest L J & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.